Jim Cramer's Mad Money Stock Recap Aug. 7th
The Fed Gets a Clue: Kellogg (NYSE: K - News), Schlumberger (NYSE: SLB - News), Kimberly-Clark (NYSE: KMB - News), Fannie Mae (NYSE: FNM - News)
Commenting on the Fed announcement, Cramer said, "What we got was, frankly, what we needed, and we rallied." The Fed decided to allow the interest rate to remain at 5.5%, a move Cramer says shows the Fed "may be heartless, but its not clueless." He predicts the Fed is heading towards a rate cut, which he thinks will happen in October. He also detected a hint at government intervention to solve the housing crisis, and Cramer thinks the Treasury Secretary or the President may ask Fannie Mae to help relieve some of the credit pressure. In the meantime, Cramer would buy defensive stocks such as K, SLB and KMB and would concentrate on oil, agriculture and infrastructure.
Getting Defensive: Unilever (NYSE: UN - News)
Cramer likes UN as a defensive stock to depend on in down times, because it a major producer of packaged foods, is international and therefore unaffected by US credit problems, and has a generous 3.6% dividend cushion. In addition, nearly a third of its sales come from emerging countries; "It's a play on people getting richer around the world," Cramer said. Since the stock has risen a bit, Cramer suggests letting it drop a few points before buying.
CEO Interview: Doron Gerstel Syneron Medical Ltd. (NasdaqGS: ELOS - News)
Cramer was puzzled that Syneron, which reported 52% US growth and 21% European growth, got hammered after its phenomenal quarter. The company also has a deal with Procter & Gamble to develop a non-invasive skin product and a fat remover. The mystery was solved when Cramer spoke with CEO Doron Gerstel who commented that everyone is jumping on the "aesthetic bandwagon; The main concern the market has is that it's looking at the competition, and more and more companies are doing initial public offerings," he said. "They're worried about saturation in the sector." Cramer commented this may be a cause for serious concern and suggested holding off buying ELOS until it becomes clear whether or not the company will be pressured by new IPOs.
Published By SeekingAlpha
Commenting on the Fed announcement, Cramer said, "What we got was, frankly, what we needed, and we rallied." The Fed decided to allow the interest rate to remain at 5.5%, a move Cramer says shows the Fed "may be heartless, but its not clueless." He predicts the Fed is heading towards a rate cut, which he thinks will happen in October. He also detected a hint at government intervention to solve the housing crisis, and Cramer thinks the Treasury Secretary or the President may ask Fannie Mae to help relieve some of the credit pressure. In the meantime, Cramer would buy defensive stocks such as K, SLB and KMB and would concentrate on oil, agriculture and infrastructure.
Getting Defensive: Unilever (NYSE: UN - News)
Cramer likes UN as a defensive stock to depend on in down times, because it a major producer of packaged foods, is international and therefore unaffected by US credit problems, and has a generous 3.6% dividend cushion. In addition, nearly a third of its sales come from emerging countries; "It's a play on people getting richer around the world," Cramer said. Since the stock has risen a bit, Cramer suggests letting it drop a few points before buying.
CEO Interview: Doron Gerstel Syneron Medical Ltd. (NasdaqGS: ELOS - News)
Cramer was puzzled that Syneron, which reported 52% US growth and 21% European growth, got hammered after its phenomenal quarter. The company also has a deal with Procter & Gamble to develop a non-invasive skin product and a fat remover. The mystery was solved when Cramer spoke with CEO Doron Gerstel who commented that everyone is jumping on the "aesthetic bandwagon; The main concern the market has is that it's looking at the competition, and more and more companies are doing initial public offerings," he said. "They're worried about saturation in the sector." Cramer commented this may be a cause for serious concern and suggested holding off buying ELOS until it becomes clear whether or not the company will be pressured by new IPOs.
Published By SeekingAlpha
posted by Stock Administrator @ 7:45 AM
0 Comments
